Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Global Biologics Contract Manufacturing Market Insights, Forecast to 2030

Global Biologics Contract Manufacturing Market Insights, Forecast to 2030

Industry: Service & Software

Published: 2024-04-12

Pages: 109 Pages

Report ld: 2920791

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.

Market Analysis and Insights: Global Biologics Contract Manufacturing Market
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Biologics Contract Manufacturing include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, SamsungBiologics, Abbvie, Catalent and Bioreliance, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Biologics Contract Manufacturing is widely used in various fields, such as Oncology, Immunological Disorders, Cardiovascular Disorders (CVDs) and Hematological Disorders, etc. Oncology provides greatest supports to the Biologics Contract Manufacturing industry development. In 2023, global % revenue of Biologics Contract Manufacturing went into Oncology filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biologics Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biologics Contract Manufacturing, also provides the revenue of main regions and countries. of the upcoming market potential for Biologics Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics Contract Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biologics Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biologics Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation
  • Report Metric

  • Details

  • Report Title

  • Global Biologics Contract Manufacturing Market Insights, Forecast to 2030

  • Market Size Available for Years

  • 2024-2030

  • Global Biologics Contract Manufacturing Companies Covered

  • Wuxi Biologics

    Abzena Ltd.

    FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

    Boehringer Ingelheim GmbH

    Lonza

    SamsungBiologics

    Abbvie

    Catalent

    Bioreliance

    Thermo Fischer (Patheon)

    Eurofins CDMO

  • Global Biologics Contract Manufacturing Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Biologics Contract Manufacturing Market, Segment by Type

  • MABs

    Recombinant Protein

    Others

  • Global Biologics Contract Manufacturing Market, Segment by Application

  • Oncology

    Immunological Disorders

    Cardiovascular Disorders (CVDs)

    Hematological Disorders

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biologics Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MABs
1.2.3 Recombinant Protein
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Immunological Disorders
1.3.4 Cardiovascular Disorders (CVDs)
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Manufacturing Market Perspective (2019-2030)
2.2 Global Biologics Contract Manufacturing Growth Trends by Region
2.2.1 Biologics Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Biologics Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Biologics Contract Manufacturing Market Dynamics
2.3.1 Biologics Contract Manufacturing Industry Trends
2.3.2 Biologics Contract Manufacturing Market Drivers
2.3.3 Biologics Contract Manufacturing Market Challenges
2.3.4 Biologics Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biologics Contract Manufacturing by Players
3.1.1 Global Biologics Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biologics Contract Manufacturing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biologics Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biologics Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Manufacturing Revenue in 2023
3.5 Global Key Players of Biologics Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Biologics Contract Manufacturing, Product and Application
3.7 Global Key Players of Biologics Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Manufacturing Breakdown Data by Type
4.1 Global Biologics Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Biologics Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Biologics Contract Manufacturing Breakdown Data by Application
5.1 Global Biologics Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Biologics Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Contract Manufacturing Market Size (2019-2030)
6.2 North America Biologics Contract Manufacturing Market Size by Type
6.2.1 North America Biologics Contract Manufacturing Market Size by Type (2019-2024)
6.2.2 North America Biologics Contract Manufacturing Market Size by Type (2025-2030)
6.2.3 North America Biologics Contract Manufacturing Market Share by Type (2019-2030)
6.3 North America Biologics Contract Manufacturing Market Size by Application
6.3.1 North America Biologics Contract Manufacturing Market Size by Application (2019-2024)
6.3.2 North America Biologics Contract Manufacturing Market Size by Application (2025-2030)
6.3.3 North America Biologics Contract Manufacturing Market Share by Application (2019-2030)
6.4 North America Biologics Contract Manufacturing Market Size by Country
6.4.1 North America Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biologics Contract Manufacturing Market Size by Country (2019-2024)
6.4.3 North America Biologics Contract Manufacturing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biologics Contract Manufacturing Market Size (2019-2030)
7.2 Europe Biologics Contract Manufacturing Market Size by Type
7.2.1 Europe Biologics Contract Manufacturing Market Size by Type (2019-2024)
7.2.2 Europe Biologics Contract Manufacturing Market Size by Type (2025-2030)
7.2.3 Europe Biologics Contract Manufacturing Market Share by Type (2019-2030)
7.3 Europe Biologics Contract Manufacturing Market Size by Application
7.3.1 Europe Biologics Contract Manufacturing Market Size by Application (2019-2024)
7.3.2 Europe Biologics Contract Manufacturing Market Size by Application (2025-2030)
7.3.3 Europe Biologics Contract Manufacturing Market Share by Application (2019-2030)
7.4 Europe Biologics Contract Manufacturing Market Size by Country
7.4.1 Europe Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biologics Contract Manufacturing Market Size by Country (2019-2024)
7.4.3 Europe Biologics Contract Manufacturing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biologics Contract Manufacturing Market Size (2019-2030)
8.2 China Biologics Contract Manufacturing Market Size by Type
8.2.1 China Biologics Contract Manufacturing Market Size by Type (2019-2024)
8.2.2 China Biologics Contract Manufacturing Market Size by Type (2025-2030)
8.2.3 China Biologics Contract Manufacturing Market Share by Type (2019-2030)
8.3 China Biologics Contract Manufacturing Market Size by Application
8.3.1 China Biologics Contract Manufacturing Market Size by Application (2019-2024)
8.3.2 China Biologics Contract Manufacturing Market Size by Application (2025-2030)
8.3.3 China Biologics Contract Manufacturing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biologics Contract Manufacturing Market Size (2019-2030)
9.2 Asia Biologics Contract Manufacturing Market Size by Type
9.2.1 Asia Biologics Contract Manufacturing Market Size by Type (2019-2024)
9.2.2 Asia Biologics Contract Manufacturing Market Size by Type (2025-2030)
9.2.3 Asia Biologics Contract Manufacturing Market Share by Type (2019-2030)
9.3 Asia Biologics Contract Manufacturing Market Size by Application
9.3.1 Asia Biologics Contract Manufacturing Market Size by Application (2019-2024)
9.3.2 Asia Biologics Contract Manufacturing Market Size by Application (2025-2030)
9.3.3 Asia Biologics Contract Manufacturing Market Share by Application (2019-2030)
9.4 Asia Biologics Contract Manufacturing Market Size by Region
9.4.1 Asia Biologics Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biologics Contract Manufacturing Market Size by Region (2019-2024)
9.4.3 Asia Biologics Contract Manufacturing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Wuxi Biologics
11.1.1 Wuxi Biologics Company Details
11.1.2 Wuxi Biologics Business Overview
11.1.3 Wuxi Biologics Biologics Contract Manufacturing Introduction
11.1.4 Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.1.5 Wuxi Biologics Recent Developments
11.2 Abzena Ltd.
11.2.1 Abzena Ltd. Company Details
11.2.2 Abzena Ltd. Business Overview
11.2.3 Abzena Ltd. Biologics Contract Manufacturing Introduction
11.2.4 Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.2.5 Abzena Ltd. Recent Developments
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Details
11.4.2 Boehringer Ingelheim GmbH Business Overview
11.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Introduction
11.4.4 Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.4.5 Boehringer Ingelheim GmbH Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Biologics Contract Manufacturing Introduction
11.5.4 Lonza Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.5.5 Lonza Recent Developments
11.6 SamsungBiologics
11.6.1 SamsungBiologics Company Details
11.6.2 SamsungBiologics Business Overview
11.6.3 SamsungBiologics Biologics Contract Manufacturing Introduction
11.6.4 SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.6.5 SamsungBiologics Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Biologics Contract Manufacturing Introduction
11.7.4 Abbvie Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.7.5 Abbvie Recent Developments
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Biologics Contract Manufacturing Introduction
11.8.4 Catalent Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.8.5 Catalent Recent Developments
11.9 Bioreliance
11.9.1 Bioreliance Company Details
11.9.2 Bioreliance Business Overview
11.9.3 Bioreliance Biologics Contract Manufacturing Introduction
11.9.4 Bioreliance Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.9.5 Bioreliance Recent Developments
11.10 Thermo Fischer (Patheon)
11.10.1 Thermo Fischer (Patheon) Company Details
11.10.2 Thermo Fischer (Patheon) Business Overview
11.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Introduction
11.10.4 Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.10.5 Thermo Fischer (Patheon) Recent Developments
11.11 Eurofins CDMO
11.11.1 Eurofins CDMO Company Details
11.11.2 Eurofins CDMO Business Overview
11.11.3 Eurofins CDMO Biologics Contract Manufacturing Introduction
11.11.4 Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.11.5 Eurofins CDMO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of MABs
    Table 3. Key Players of Recombinant Protein
    Table 4. Key Players of Others
    Table 5. Global Biologics Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Biologics Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Biologics Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Biologics Contract Manufacturing Market Share by Region (2019-2024)
    Table 9. Global Biologics Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Biologics Contract Manufacturing Market Share by Region (2025-2030)
    Table 11. Biologics Contract Manufacturing Market Trends
    Table 12. Biologics Contract Manufacturing Market Drivers
    Table 13. Biologics Contract Manufacturing Market Challenges
    Table 14. Biologics Contract Manufacturing Market Restraints
    Table 15. Global Biologics Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Biologics Contract Manufacturing Revenue Share by Players (2019-2024)
    Table 17. Global Top Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2023)
    Table 18. Global Biologics Contract Manufacturing Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Biologics Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Biologics Contract Manufacturing, Headquarters and Area Served
    Table 21. Global Key Players of Biologics Contract Manufacturing, Product and Application
    Table 22. Global Key Players of Biologics Contract Manufacturing, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Biologics Contract Manufacturing Revenue Market Share by Type (2019-2024)
    Table 26. Global Biologics Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Biologics Contract Manufacturing Revenue Market Share by Type (2025-2030)
    Table 28. Global Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Biologics Contract Manufacturing Revenue Share by Application (2019-2024)
    Table 30. Global Biologics Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Biologics Contract Manufacturing Revenue Share by Application (2025-2030)
    Table 32. North America Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Biologics Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Biologics Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Biologics Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Wuxi Biologics Company Details
    Table 65. Wuxi Biologics Business Overview
    Table 66. Wuxi Biologics Biologics Contract Manufacturing Product
    Table 67. Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 68. Wuxi Biologics Recent Developments
    Table 69. Abzena Ltd. Company Details
    Table 70. Abzena Ltd. Business Overview
    Table 71. Abzena Ltd. Biologics Contract Manufacturing Product
    Table 72. Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 73. Abzena Ltd. Recent Developments
    Table 74. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
    Table 75. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
    Table 76. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product
    Table 77. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 78. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
    Table 79. Boehringer Ingelheim GmbH Company Details
    Table 80. Boehringer Ingelheim GmbH Business Overview
    Table 81. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product
    Table 82. Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 83. Boehringer Ingelheim GmbH Recent Developments
    Table 84. Lonza Company Details
    Table 85. Lonza Business Overview
    Table 86. Lonza Biologics Contract Manufacturing Product
    Table 87. Lonza Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 88. Lonza Recent Developments
    Table 89. SamsungBiologics Company Details
    Table 90. SamsungBiologics Business Overview
    Table 91. SamsungBiologics Biologics Contract Manufacturing Product
    Table 92. SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 93. SamsungBiologics Recent Developments
    Table 94. Abbvie Company Details
    Table 95. Abbvie Business Overview
    Table 96. Abbvie Biologics Contract Manufacturing Product
    Table 97. Abbvie Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 98. Abbvie Recent Developments
    Table 99. Catalent Company Details
    Table 100. Catalent Business Overview
    Table 101. Catalent Biologics Contract Manufacturing Product
    Table 102. Catalent Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 103. Catalent Recent Developments
    Table 104. Bioreliance Company Details
    Table 105. Bioreliance Business Overview
    Table 106. Bioreliance Biologics Contract Manufacturing Product
    Table 107. Bioreliance Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 108. Bioreliance Recent Developments
    Table 109. Thermo Fischer (Patheon) Company Details
    Table 110. Thermo Fischer (Patheon) Business Overview
    Table 111. Thermo Fischer (Patheon) Biologics Contract Manufacturing Product
    Table 112. Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 113. Thermo Fischer (Patheon) Recent Developments
    Table 114. Eurofins CDMO Company Details
    Table 115. Eurofins CDMO Business Overview
    Table 116. Eurofins CDMO Biologics Contract Manufacturing Product
    Table 117. Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
    Table 118. Eurofins CDMO Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Biologics Contract Manufacturing Market Share by Type: 2023 VS 2030
    Figure 3. MABs Features
    Figure 4. Recombinant Protein Features
    Figure 5. Others Features
    Figure 6. Global Biologics Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Biologics Contract Manufacturing Market Share by Application: 2023 VS 2030
    Figure 8. Oncology Case Studies
    Figure 9. Immunological Disorders Case Studies
    Figure 10. Cardiovascular Disorders (CVDs) Case Studies
    Figure 11. Hematological Disorders Case Studies
    Figure 12. Others Case Studies
    Figure 13. Biologics Contract Manufacturing Report Years Considered
    Figure 14. Global Biologics Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Biologics Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Biologics Contract Manufacturing Market Share by Region: 2023 VS 2030
    Figure 17. Global Biologics Contract Manufacturing Market Share by Players in 2023
    Figure 18. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Biologics Contract Manufacturing Revenue in 2023
    Figure 20. North America Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Biologics Contract Manufacturing Market Share by Type (2019-2030)
    Figure 22. North America Biologics Contract Manufacturing Market Share by Application (2019-2030)
    Figure 23. North America Biologics Contract Manufacturing Market Share by Country (2019-2030)
    Figure 24. United States Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Biologics Contract Manufacturing Market Share by Type (2019-2030)
    Figure 28. Europe Biologics Contract Manufacturing Market Share by Application (2019-2030)
    Figure 29. Europe Biologics Contract Manufacturing Market Share by Country (2019-2030)
    Figure 30. Germany Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Biologics Contract Manufacturing Market Share by Type (2019-2030)
    Figure 38. China Biologics Contract Manufacturing Market Share by Application (2019-2030)
    Figure 39. Asia Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Biologics Contract Manufacturing Market Share by Type (2019-2030)
    Figure 41. Asia Biologics Contract Manufacturing Market Share by Application (2019-2030)
    Figure 42. Asia Biologics Contract Manufacturing Market Share by Region (2019-2030)
    Figure 43. Japan Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Country (2019-2030)
    Figure 53. Brazil Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Wuxi Biologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 60. Abzena Ltd. Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 61. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 63. Lonza Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 64. SamsungBiologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 65. Abbvie Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 66. Catalent Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 67. Bioreliance Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 68. Thermo Fischer (Patheon) Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 69. Eurofins CDMO Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed

Description

Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.

Market Analysis and Insights: Global Biologics Contract Manufacturing Market
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Biologics Contract Manufacturing include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, SamsungBiologics, Abbvie, Catalent and Bioreliance, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Biologics Contract Manufacturing is widely used in various fields, such as Oncology, Immunological Disorders, Cardiovascular Disorders (CVDs) and Hematological Disorders, etc. Oncology provides greatest supports to the Biologics Contract Manufacturing industry development. In 2023, global % revenue of Biologics Contract Manufacturing went into Oncology filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biologics Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biologics Contract Manufacturing, also provides the revenue of main regions and countries. of the upcoming market potential for Biologics Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics Contract Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biologics Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biologics Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation
Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biologics Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Related Reports

  • Global Biologics Contract Manufacturing Market Research Report 2024

    Global Biologics Contract Manufacturing Market Research Report 2024

    Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

    selected

    Published: 2024-02-26

    page

    Pages: 87

    USD 2900.00

    (Single User License)

  • Biologics Contract Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Biologics Contract Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

    selected

    Published: 2024-01-11

    page

    Pages: 102

    USD 3950.00

    (Single User License)

  • Global Biologics Contract Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031

    Global Biologics Contract Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031

    The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

    selected

    Published: 2025-11-16

    page

    Pages: 144

    USD 4900.00

    (Single User License)

  • Global Biologics Contract Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    Global Biologics Contract Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    The global Biologics Contract Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

    selected

    Published: 2025-11-16

    page

    Pages: 94

    USD 4250.00

    (Single User License)

  • Global Biologics Contract Manufacturing Market Research Report 2024

    Global Biologics Contract Manufacturing Market Research Report 2024

    Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

    selected

    Published: 2024-02-26

    page

    Pages: 87

    USD 2900.00 ()
  • Biologics Contract Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Biologics Contract Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

    selected

    Published: 2024-01-11

    page

    Pages: 102

    USD 3950.00 ()
  • Global Biologics Contract Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031

    Global Biologics Contract Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031

    The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

    selected

    Published: 2025-11-16

    page

    Pages: 144

    USD 4900.00 ()
  • Global Biologics Contract Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    Global Biologics Contract Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    The global Biologics Contract Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

    selected

    Published: 2025-11-16

    page

    Pages: 94

    USD 4250.00 ()
Global Biologics Contract Manufacturing Market Insights, Forecast to 2030

Industry: Service & Software

Published: 2024-04-12

Pages: 109 Pages

Report ld: 2920791

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

Online

JOHN WANG

English

English

Offline

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE